Their goal was to find a cure for cancer, but the whole world recognized them for developing the first vaccine against the coronavirus. The founders of the German company BioNTech, Ugur Sahin and Ozlem Tureci, now turn their attention back to cancer. VOA’s Dilge Timocin interviewed Ugur Sahin and files this report. Camera: Tezcan Taskiran

your ad here

leave a reply